The Dubai branch of BD (Becton, Dickinson, and Company), a medical technology company, presents its latest innovations and solutions focused on patient safety to support clinicians’ efforts to move from piecemeal interventions to a total systems approach for safety.

“The pandemic put the healthcare sector to the test in terms of stability and preparedness, demonstrating the need for healthcare providers to adopt advanced technology to meet the growing needs of patients,” said Maher Elhassan, Vice President and General Manager, BD Middle East, North Africa, and Turkey.

At Arab Health 2022, the company will demonstrate the full potential of its innovations through the collaboration of its Medical segment with Medication Management Systems and Medication Delivery Systems, and the BD Interventional segment. BD will display a series of solutions that will focus on the prevention of potential medication errors and Healthcare-Associated Infections (HAIs) alongside innovations that will empower medical professionals to perform timely, accurate, and appropriate diagnostics practices to support effective decision making in providing the safest and most effective care possible in the region.

Additionally, at Medlab 2022, the company’s Lifesciences segment will showcase integrated diagnostic solutions and services, including safe and integrated specimen collection, specimen diagnosis, and data management for better patient comfort. The company will also present solutions that incorporate artificial intelligence to drive laboratory efficiency with customized microbiology automation platforms and dedicated value-added services.